Peter Orendáš

484 total citations
22 papers, 408 citations indexed

About

Peter Orendáš is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Peter Orendáš has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Peter Orendáš's work include Cancer, Lipids, and Metabolism (11 papers), Lipoproteins and Cardiovascular Health (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Peter Orendáš is often cited by papers focused on Cancer, Lipids, and Metabolism (11 papers), Lipoproteins and Cardiovascular Health (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Peter Orendáš collaborates with scholars based in Slovakia, Czechia and Austria. Peter Orendáš's co-authors include Monika Kassayová, Bianka Bojková, Peter Kubatka, Terézia Kisková, Karol Kajo, Martin Péč, I Ahlers, E Ahlersová, Nikita Bobrov and Marián Adamkov and has published in prestigious journals such as European Journal of Cancer Prevention, International Journal of Experimental Pathology and Pathology & Oncology Research.

In The Last Decade

Peter Orendáš

22 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Orendáš Slovakia 13 217 103 88 67 56 22 408
Li Hua Zheng China 12 287 1.3× 108 1.0× 22 0.3× 76 1.1× 24 0.4× 19 490
Effat Farrokhi Iran 14 189 0.9× 54 0.5× 38 0.4× 26 0.4× 56 1.0× 45 455
Thi Thu Trang Tran France 10 223 1.0× 43 0.4× 25 0.3× 24 0.4× 104 1.9× 17 501
Chang Yan Chen United States 11 313 1.4× 72 0.7× 39 0.4× 81 1.2× 14 0.3× 12 461
Sabrina Uda Italy 10 142 0.7× 44 0.4× 19 0.2× 34 0.5× 79 1.4× 14 591
Martine Collinet France 11 234 1.1× 57 0.6× 22 0.3× 21 0.3× 39 0.7× 17 446
Jane R. Evans United States 8 260 1.2× 45 0.4× 19 0.2× 81 1.2× 141 2.5× 9 524
Céline Gaudel France 12 441 2.0× 41 0.4× 21 0.2× 30 0.4× 84 1.5× 14 661
Anna-Marie Brown United Kingdom 11 271 1.2× 35 0.3× 18 0.2× 26 0.4× 105 1.9× 14 534
Franck Hansmannel France 13 243 1.1× 45 0.4× 14 0.2× 29 0.4× 66 1.2× 22 554

Countries citing papers authored by Peter Orendáš

Since Specialization
Citations

This map shows the geographic impact of Peter Orendáš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Orendáš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Orendáš more than expected).

Fields of papers citing papers by Peter Orendáš

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Orendáš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Orendáš. The network helps show where Peter Orendáš may publish in the future.

Co-authorship network of co-authors of Peter Orendáš

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Orendáš. A scholar is included among the top collaborators of Peter Orendáš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Orendáš. Peter Orendáš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassayová, Monika, Nikita Bobrov, Ladislav Strojný, et al.. (2016). Anticancer and Immunomodulatory Effects of Lactobacillus plantarum LS/07, Inulin and Melatonin in NMU-induced Rat Model of Breast Cancer.. PubMed. 36(6). 2719–28. 36 indexed citations
2.
Orendáš, Peter, et al.. (2015). Trophic spectrum of adult Salamandra salamandra in the Carpathians with the first note on food intake by the species during winter. Herpetology notes. 8. 371–377. 7 indexed citations
3.
Bojková, Bianka, Peter Orendáš, Peter Kubatka, et al.. (2014). Positive and negative effects of glitazones in carcinogenesis: Experimental models vs. clinical practice. Pathology - Research and Practice. 210(8). 465–472. 10 indexed citations
4.
Kubatka, Peter, Bianka Bojková, Monika Kassayová, et al.. (2014). Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model. Acta Histochemica. 116(8). 1454–1461. 27 indexed citations
5.
Kisková, Terézia, Rastislav Jendželovský, Alexandra Maier‐Salamon, et al.. (2014). Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats. European Journal of Cancer Prevention. 23(6). 506–513. 26 indexed citations
6.
Kassayová, Monika, Nikita Bobrov, Ladislav Strojný, et al.. (2014). Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis.. PubMed. 34(9). 4969–75. 47 indexed citations
7.
Orendáš, Peter, Peter Kubatka, Bianka Bojková, et al.. (2014). Melatonin potentiates the anti‐tumour effect of pravastatin in rat mammary gland carcinoma model. International Journal of Experimental Pathology. 95(6). 401–410. 37 indexed citations
8.
Kubatka, Peter, Karol Kajo, Katarína Adamicová, et al.. (2012). Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment. Neoplasma. 59(5). 516–523. 16 indexed citations
9.
Kubatka, Peter, Jozef Škarda, Karol Kajo, et al.. (2012). Preventive effects of fluvastatin in rat mammary carcinogenesis. European Journal of Cancer Prevention. 22(4). 352–357. 13 indexed citations
10.
Orendáš, Peter, Peter Kubatka, Karol Kajo, et al.. (2012). Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis. Neoplasma. 59(4). 469–474. 10 indexed citations
11.
Bojková, Bianka, Karol Kajo, Peter Kubatka, et al.. (2012). Rosiglitazone Shows Partial Oncostatic Effect in Rat Mammary Carcinogenesis. Neoplasma. 60(1). 46–55. 5 indexed citations
12.
Kubatka, Peter, Karol Kajo, Martin Péč, et al.. (2011). Rosuvastatin in the chemoprevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats. Acta veterinaria. 61(5-6). 445–460. 6 indexed citations
13.
Kisková, Terézia, Cem Ekmekçioğlu, Peter Orendáš, et al.. (2011). A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. European Journal of Cancer Prevention. 21(2). 163–170. 38 indexed citations
14.
Bojková, Bianka, Martin Péč, Peter Kubatka, et al.. (2011). Metabolic Effects of Pioglitazone in Chemically-Induced Mammary Carcinogenesis in Rats. Pathology & Oncology Research. 17(4). 887–892. 5 indexed citations
15.
Kubatka, Peter, et al.. (2011). Antineoplastic effects of simvastatin in experimental breast cancer.. PubMed. 24(1). 41–5. 13 indexed citations
16.
Bojková, Bianka, Karol Kajo, Martin Péč, et al.. (2010). Pioglitazone in chemically induced mammary carcinogenesis in rats. European Journal of Cancer Prevention. 19(5). 379–384. 25 indexed citations
17.
Bojková, Bianka, et al.. (2009). Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma. 56(3). 269–274. 36 indexed citations
18.
Orendáš, Peter, Monika Kassayová, Karol Kajo, et al.. (2009). Celecoxib and melatonin in prevention of female rat mammary carcinogenesis. Neoplasma. 56(3). 252–258. 13 indexed citations
19.
Bojková, Bianka, et al.. (2008). Prolonged melatonin administration in 6-month-old Sprague-Dawley rats: metabolic alterations. Acta Physiologica Hungarica. 95(1). 65–76. 26 indexed citations
20.
Orendáš, Peter, I Ahlers, Peter Kubatka, et al.. (2007). Etoricoxib in the Prevention of Rat Mammary Carcinogenesis. Acta Veterinaria Brno. 76(4). 613–618. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Hua Zheng Breakdown of academic impact, for papers by Effat Farrokhi Breakdown of academic impact, for papers by Thi Thu Trang Tran Breakdown of academic impact, for papers by Chang Yan Chen Breakdown of academic impact, for papers by Sabrina Uda Breakdown of academic impact, for papers by Martine Collinet Breakdown of academic impact, for papers by Jane R. Evans Breakdown of academic impact, for papers by Céline Gaudel Breakdown of academic impact, for papers by Anna-Marie Brown Breakdown of academic impact, for papers by Franck Hansmannel
Rankless by CCL
2026